Avenue Therapeutics (ATXI) Stock Chart & Stock Price History $0.36 +0.01 (+2.83%) As of 10:35 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Avenue Therapeutics Stock Price Performance The Avenue Therapeutics (ATXI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 90.02%, with a year-to-date return of -81.99%. In the past month, the stock has increased 67.50%, reflecting recent market activity. As of the latest close, Avenue Therapeutics traded at $0.35 with a market cap of $1.12 million and volume of 923 shares. Five years ago, the stock traded at a split-adjusted price of $11,160.00, representing a 100.00% decrease over that period. At the time, it had a market cap of $161.46 million and a volume of 460 shares. Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.29%1 Month Performance+67.50%3 Month Performance+30.26%Year-To-Date Performance-81.99%1 Year Performance-90.02%5 Year Performance-100.00% ATXI Stock Chart for Wednesday, July, 16, 2025 ATXI Chart by TradingView Avenue Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/16/2025$0.35$0.36+2.83%$0.44$0.355,870 shs$1.15 million07/15/2025$0.40$0.35-12.40%$0.42$0.35923 shs$1.12 million07/14/2025$0.37$0.40+9.59%$0.40$0.398,213 shs$1.27 million07/11/2025$0.25$0.37+44.84%$0.40$0.2532,282 shs$1.16 million07/10/2025$0.23$0.25+8.02%$0.36$0.243,567 shs$802,000.0007/09/2025$0.23$0.23$0.36$0.2220,702 shs$743,000.0007/08/2025$0.32$0.23-26.82%$0.36$0.2220,702 shs$743,000.0007/07/2025$0.34$0.32-6.21%$0.34$0.224,061 shs$1.02 million07/04/2025$0.34$0.34$0.34$0.34357 shs$1.08 million07/03/2025$0.26$0.34+31.80%$0.34$0.34357 shs$1.08 million Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/02/2025$0.35$0.26-26.31%$0.34$0.261,043 shs$821,000.0007/01/2025$0.20$0.35+74.39%$0.38$0.2828,638 shs$1.11 million06/30/2025$0.24$0.20-16.51%$0.20$0.20305 shs$639,000.0006/27/2025$0.24$0.24$0.24$0.24606 shs$765,000.0006/26/2025$0.24$0.24-0.08%$0.28$0.24457 shs$765,000.0006/25/2025$0.24$0.24+0.04%$0.24$0.243,273 shs$766,000.0006/24/2025$0.24$0.24+0.17%$0.38$0.2414,118 shs$766,000.0006/23/2025$0.30$0.24-19.65%$0.28$0.223,170 shs$764,000.0006/20/2025$0.26$0.30+15.14%$0.34$0.2435,239 shs$951,000.0006/19/2025$0.26$0.26$0.26$0.2667 shs$826,000.0006/18/2025$0.26$0.26$0.28$0.228,143 shs$826,000.0006/17/2025$0.22$0.26+20.64%$0.28$0.228,143 shs$826,000.0006/16/2025$0.21$0.22+3.31%$0.22$0.222,145 shs$685,000.00 Related Companies Matinas Biopharma Stock Price Chart VivoSim Labs Stock Price Chart Redhill Biopharma Stock Price Chart CNS Pharmaceuticals Stock Price Chart Dermata Therapeutics Stock Price Chart Tharimmune Stock Price Chart Soligenix Stock Price Chart Spruce Biosciences Stock Price Chart Clearmind Medicine Stock Price Chart Revelation Biosciences Stock Price Chart Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXI) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
